Avantect — Early Cancer Detection

Typography

Rubik sets every heading, label, and button. Inter carries body copy at a generous 1.55–1.7 line height, because clinical text gets read slowly and carefully.

Families

Display — Rubik

Aa Bb Cc

Medium 500 and Semibold 600. Tight tracking at large sizes. Never lighter than 400.

Body — Inter

Aa Bb Cc

Regular 400 for prose, Medium 500 for emphasis. Body copy caps at a 40rem measure.

Scale

Every heading level, at its rendered size.

display4rem / 1.1Hero statements only, once per page.

Detecting cancer earlier

h13rem / 1.1Page title.

Detecting cancer earlier

h22.25rem / 1.2Major section.

Detecting cancer earlier

h31.875rem / 1.25Sub-section.

Detecting cancer earlier

h41.5rem / 1.3Card and block titles.

Detecting cancer earlier

Body and support styles

text-body-lg — intros and hero support

Avantect® is designed to detect signals associated with cancer at its earliest, most treatable stages.

text-body — default prose

The test analyses 5hmC signals in cell-free DNA. Results are reported as signal detected or signal not detected, and are intended to support — never replace — clinical judgement.

text-body-sm — secondary and captions

Turnaround is typically 14 days from sample receipt.

Eyebrow — uppercase section marker, purple

For Healthcare Providers

text-caption — regulatory and footnotes

This test was developed and its performance characteristics determined by ClearNote Health. It has not been cleared or approved by the U.S. Food and Drug Administration.

Rules

The parts that break the brand when ignored.

  • One display or h1 per page. Never both.
  • Body measure stays under 40rem — long clinical lines lose readers.
  • Sentence case everywhere except eyebrows, which are uppercase with 0.12em tracking.
  • Avantect® carries the registration mark on first mention only.
  • Every clinical figure carries an inline citation marker.